Integrated DNA Technologies and Aldevron® Activate Strategic Partnership to Deliver Key CRISPR Components to Cell and Gene Therapy Developers

Integrated DNA Technologies will sell Aldevron cGMP-manufactured CRISPR nucleases to enable customers to rapidly transition from discovery to clinic.

Mural Health Raises $8M Led by Bessemer Venture Partners to Accelerate Growth

Mural Health Raises $8M Led by Bessemer Venture Partners to Accelerate Growth Funding enables Mural Health to expand its Mural Link platform to modernize the clinical trial participant experience

AVIA Launches Innovative AI Labs, AI Co-pilot for Digital Health Transformation

AVIA's newest AI-focused initiative aims to share practical application of AI to better inform - and transform - the healthcare industry

Mount Nittany Medical Center Increases Accuracy and Efficiency of Vancomycin Dosing Using InsightRX Model-Informed Precision Dosing Platform

Mount Nittany Medical Center Increases Accuracy and Efficiency of Vancomycin Dosing Using InsightRX Model-Informed Precision Dosing Platform

Kalderos Adds Powerful Features to Commercial Drug Discount Monitoring Solution

Kalderos Adds Powerful Features to Commercial Drug Discount Monitoring Solution - Drug Discount Management Leader Delivers New Tools to Tackle Billions in Overpaid Commercial Rebates

Watson-Marlow Fluid Technology Solutions to Showcase Fluid Path Product Range at ISPE Boston

Visit stand W113 to meet WMFTS engineers and discuss single use fluid path processes at ISPE Annual Product Show

BioIVT Webinar Will Discuss How to Manage Uncooperative Drugs in In Vitro Transporter Research

This presentation will offer practical strategies to achieve definitive results when researching unstable, sticky, or insoluble compounds.

Alfa Chemistry Unveils Revitalized Strong/Weak Acid Cation Resin and Base Anion Resin Lineup

CD ComputaBio Unveils Cutting-Edge Advances in Antibody Drug Design and Development

CD ComputaBio Launches Revolutionary Antibody De Novo Design Service Pioneering Precision Medicine with AI

Genedata Collaborates with Astellas to Facilitate Regenerative Cell Therapy Product Development

Ann Graham, Founder of MIB Agents, Joins NCCN Guidelines Panel

Ann Graham, Founder and Executive Director of MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to making it better for its community of patients, caregivers, doctors, and researchers, has officially joined the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Panel for Bone Cancer, in the role of patient advocate.

CD Formulation Demonstrates Expertise in CAR-T and CAR-NK Cell Development for Drug Delivery Systems

Daptomycin ReadyMade™ Solution to Power Up Spectrum and Microbiology Applications

Verdot expands offering with FlexiPro™ TFF system to meet growing industry demand

Leading downstream bioprocessing technology company, Verdot, announces the launch of its FlexiPro™ TFF, a multipurpose tangential flow filtration (TFF) GMP system, in response to rising industry demand for gene therapy, vaccine, and mRNA-based therapeutics.

Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance

Custom Stainless Enclosures Highlights 4Xxtreme® Double Seal Enclosures™

Invitation to learn from the best: Evening of insights and networking will honor a clinical data management stalwart

Invitation to learn from the best: Evening of insights and networking will honor a clinical data management stalwart Prof Deborah Ashby to give the 2023 Sally Hollis Memorial Lecture in Macclesfield

BRIM closes a $45.8 million rights issue early to accelerate its pipeline of regenerative peptides

BRIM Biotechnology, Inc. (“BRIM,” TPEx 6885), a clinical-stage biotechnology company focusing on developing regenerative peptides for ophthalmology and degenerative joint diseases, announced today that 22,500 shares have been issued at a premium of NT$65 (~US$2.03), raising a total of NT$1.4625 billion (~US$45.8 million). The rights issue was fully paid on 31st August 2023, four days early compared to the scheduled date of 4th September.

Torx® Software announces global drug discovery collaboration with CDD Vault®

Torx® Software Limited has launched a major international collaboration with CDD Vault, which will create a shared digital ecosystem for drug discovery data